Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 have?
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 has 451 citations in the OpenAlex counts ScholarIQ stores.
When was Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 published?
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 has 2022 year in the ScholarIQ index.
What is the open-access status of Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1?
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 has green oa status in the ScholarIQ index.
What is the DOI of Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1?
The DOI for Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 is on the source record.
What is the PMID of Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1?
The PMID for Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 is on the source record.
What is the OpenAlex record for Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1?
The OpenAlex for Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 is on the source record.